Industry Consolidation

  • Published on
    13-Apr-2017

  • View
    198

  • Download
    0

Embed Size (px)

Transcript

<ul><li><p>OIS@AAO INDUSTRY CONSOLIDATION </p><p>Jim Mazzo Chairman &amp; CEO - AcuFocus October 16, 2014 </p><p>UNKNOWN </p><p>THE</p><p>GOOD BAD THE</p><p>&amp; T</p><p>HE</p></li><li><p>Impact of Consolida@on on Innova@on </p><p>Poten3al for greater resource alloca3on to disrup3ve innova3ons </p><p>Synergis3c benefits of combined core R&amp;D competencies </p><p>Larger commercializa3on network to speed new innova3ons to market </p><p>Disrup3on of innova3on cycle and shiIs in priori3es </p><p>Loss of ins3tu3onal knowledge &amp; exper3se </p><p>Reduced R&amp;D spending; increased compe33on for clinical &amp; regulatory resources </p><p>Are physicians &amp; pa3ents beLer served over the long-term? How do changes in the compe33ve landscape affect the industry? Can merged companys innova3on engine truly be more efficient and prolific? </p><p>THE BAD THE GOOD </p><p>THE UNKNOWN </p></li><li><p>Meet the Panel Jeff George President &amp; Global Head, Alcon William Link, PhD Managing Director, Versant Ventures Ashley McEvoy Group Chairman, Johnson &amp; Johnson David PyoQ CEO, Allergan Murthy Simhambhatla, PhD President, AbboQ Medical Op@cs </p></li></ul>